Ultragenyx Pharmaceutical Inc. (LON:0LIF)
London · Delayed Price · Currency is GBP · Price in USD 24.39
-0.02 (-0.08%)
At close: Feb 6, 2026
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of 1.69 billion as of February 6, 2026. Its market cap has decreased by -47.40% in one year.
Market Cap
1.69B
Enterprise Value
2.00B
Revenue
469.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.39
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from 746.36M to 1.69B, an increase of 126.73%. That is a compound annual growth rate of 7.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 1.69B | 2.82% |
| Dec 31, 2025 | 1.65B | -46.93% |
| Dec 31, 2024 | 3.10B | 0.60% |
| Dec 29, 2023 | 3.08B | 14.35% |
| Dec 30, 2022 | 2.70B | -36.32% |
| Dec 31, 2021 | 4.23B | -36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AJ Bell | 1.85B |
| Dunelm Group | 1.85B |
| Grafton Group | 1.80B |
| Hill & Smith | 1.79B |
| Safestore Holdings | 1.78B |
| B&M European Value Retail | 1.76B |
| Paragon Banking Group | 1.68B |
| Tate & Lyle | 1.67B |